BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32823242)

  • 1. Notoginsenoside R1 activates the Ang2/Tie2 pathway to promote angiogenesis.
    Zhong J; Lu W; Zhang J; Huang M; Lyu W; Ye G; Deng L; Chen M; Yao N; Li Y; Liu G; Liang Y; Fu J; Zhang D; Ye W
    Phytomedicine; 2020 Nov; 78():153302. PubMed ID: 32823242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo.
    Yang BR; Hong SJ; Lee SM; Cong WH; Wan JB; Zhang ZR; Zhang QW; Zhang Y; Wang YT; Lin ZX
    Chin J Integr Med; 2016 Jun; 22(6):420-9. PubMed ID: 25533511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways.
    Liu Z; Guo N; Zhang XJ
    Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-35 Inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis.
    Jiang S; Li Y; Lin T; Yuan L; Li Y; Wu S; Xia L; Shen H; Lu J
    Cell Physiol Biochem; 2016; 40(5):1105-1116. PubMed ID: 27960151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between Tie receptors modulates angiogenic activity of angiopoietin2 in endothelial progenitor cells.
    Kim KL; Shin IS; Kim JM; Choi JH; Byun J; Jeon ES; Suh W; Kim DK
    Cardiovasc Res; 2006 Dec; 72(3):394-402. PubMed ID: 17054925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis.
    Saber T; Veale DJ; Balogh E; McCormick J; NicAnUltaigh S; Connolly M; Fearon U
    PLoS One; 2011; 6(8):e23540. PubMed ID: 21858161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis.
    Kim HZ; Jung K; Kim HM; Cheng Y; Koh GY
    Biochim Biophys Acta; 2009 May; 1793(5):772-80. PubMed ID: 19339208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notoginsenoside R1 activates the NAMPT-NAD
    Zhu T; Xie WJ; Wang L; Jin XB; Meng XB; Sun GB; Sun XB
    Biomed Pharmacother; 2021 Aug; 140():111693. PubMed ID: 34029951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notoginsenoside R1 alleviates high glucose-induced inflammation and oxidative stress in HUVECs via upregulating miR-147a.
    Li XQ; Huang TY
    Kaohsiung J Med Sci; 2021 Dec; 37(12):1101-1112. PubMed ID: 34369659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells.
    Song SH; Kim KL; Lee KA; Suh W
    Biochem Biophys Res Commun; 2012 Mar; 419(2):281-6. PubMed ID: 22342979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological action of angiopoietin-2 in a fibrin matrix model of angiogenesis is associated with activation of Tie2.
    Teichert-Kuliszewska K; Maisonpierre PC; Jones N; Campbell AI; Master Z; Bendeck MP; Alitalo K; Dumont DJ; Yancopoulos GD; Stewart DJ
    Cardiovasc Res; 2001 Feb; 49(3):659-70. PubMed ID: 11166279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-2/Tie2 signaling involved in TNF-α induced peritoneal angiogenesis.
    Yuan J; Fang W; Lin A; Ni Z; Qian J
    Int J Artif Organs; 2012 Sep; 35(9):655-62. PubMed ID: 23065888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo.
    Hong SJ; Wan JB; Zhang Y; Hu G; Lin HC; Seto SW; Kwan YW; Lin ZX; Wang YT; Lee SM
    Phytother Res; 2009 May; 23(5):677-86. PubMed ID: 19107746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tie1 controls angiopoietin function in vascular remodeling and inflammation.
    Korhonen EA; Lampinen A; Giri H; Anisimov A; Kim M; Allen B; Fang S; D'Amico G; Sipilä TJ; Lohela M; Strandin T; Vaheri A; Ylä-Herttuala S; Koh GY; McDonald DM; Alitalo K; Saharinen P
    J Clin Invest; 2016 Sep; 126(9):3495-510. PubMed ID: 27548530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two natural eudesmane-type sesquiterpenes from Laggera alata inhibit angiogenesis and suppress breast cancer cell migration through VEGF- and Angiopoietin 2-mediated signaling pathways.
    Liang N; Li Y; Chung HY
    Int J Oncol; 2017 Jul; 51(1):213-222. PubMed ID: 28534941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapy.
    Shlamkovich T; Aharon L; Barton WA; Papo N
    Oncotarget; 2017 May; 8(20):33571-33585. PubMed ID: 28422724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide (LPS)-mediated angiopoietin-2-dependent autocrine angiogenesis is regulated by NADPH oxidase 2 (Nox2) in human pulmonary microvascular endothelial cells.
    Menden H; Welak S; Cossette S; Ramchandran R; Sampath V
    J Biol Chem; 2015 Feb; 290(9):5449-61. PubMed ID: 25568324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA EPIC1 promotes tumor angiogenesis via activating the Ang2/Tie2 axis in non-small cell lung cancer.
    Hou Y; Jia H; Cao Y; Zhang S; Zhang X; Wei P; Xie J; Dong W; Wang B
    Life Sci; 2021 Feb; 267():118933. PubMed ID: 33359744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.
    Daly C; Eichten A; Castanaro C; Pasnikowski E; Adler A; Lalani AS; Papadopoulos N; Kyle AH; Minchinton AI; Yancopoulos GD; Thurston G
    Cancer Res; 2013 Jan; 73(1):108-18. PubMed ID: 23149917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.